175 related articles for article (PubMed ID: 27894085)
1. Tracing anti-cancer and cancer-promoting actions of all-trans retinoic acid in breast cancer to a RARα epigenetic mechanism of mammary epithelial cell fate.
Rossetti S; Ren M; Visconti N; Corlazzoli F; Gagliostro V; Somenzi G; Yao J; Sun Y; Sacchi N
Oncotarget; 2016 Dec; 7(52):87064-87080. PubMed ID: 27894085
[TBL] [Abstract][Full Text] [Related]
2. All-trans-retinoic Acid Modulates the Plasticity and Inhibits the Motility of Breast Cancer Cells: ROLE OF NOTCH1 AND TRANSFORMING GROWTH FACTOR (TGFβ).
Zanetti A; Affatato R; Centritto F; Fratelli M; Kurosaki M; Barzago MM; Bolis M; Terao M; Garattini E; Paroni G
J Biol Chem; 2015 Jul; 290(29):17690-17709. PubMed ID: 26018078
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid improves nephrotoxic serum-induced glomerulonephritis through activation of podocyte retinoic acid receptor α.
Dai Y; Chen A; Liu R; Gu L; Sharma S; Cai W; Salem F; Salant DJ; Pippin JW; Shankland SJ; Moeller MJ; Ghyselinck NB; Ding X; Chuang PY; Lee K; He JC
Kidney Int; 2017 Dec; 92(6):1444-1457. PubMed ID: 28756872
[TBL] [Abstract][Full Text] [Related]
4. A repressive epigenetic domino effect confers susceptibility to breast epithelial cell transformation: implications for predicting breast cancer risk.
Bistulfi G; Pozzi S; Ren M; Rossetti S; Sacchi N
Cancer Res; 2006 Nov; 66(21):10308-14. PubMed ID: 17079450
[TBL] [Abstract][Full Text] [Related]
5. Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARA.
Paroni G; Fratelli M; Gardini G; Bassano C; Flora M; Zanetti A; Guarnaccia V; Ubezio P; Centritto F; Terao M; Garattini E
Oncogene; 2012 Jul; 31(29):3431-43. PubMed ID: 22056878
[TBL] [Abstract][Full Text] [Related]
6. Impaired retinoic acid (RA) signal leads to RARbeta2 epigenetic silencing and RA resistance.
Ren M; Pozzi S; Bistulfi G; Somenzi G; Rossetti S; Sacchi N
Mol Cell Biol; 2005 Dec; 25(23):10591-603. PubMed ID: 16287870
[TBL] [Abstract][Full Text] [Related]
7. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP
Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740
[TBL] [Abstract][Full Text] [Related]
8. Emerging Cancer Epigenetic Mechanisms Regulated by All-Trans Retinoic Acid.
Rossetti S; Sacchi N
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32823855
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid induces nuclear FAK translocation and reduces breast cancer cell adhesion through Moesin, FAK, and Paxillin.
Sanchez AM; Shortrede JE; Vargas-Roig LM; Flamini MI
Mol Cell Endocrinol; 2016 Jul; 430():1-11. PubMed ID: 27130522
[TBL] [Abstract][Full Text] [Related]
10. Disruption of retinoic acid receptor alpha reveals the growth promoter face of retinoic acid.
Somenzi G; Sala G; Rossetti S; Ren M; Ghidoni R; Sacchi N
PLoS One; 2007 Sep; 2(9):e836. PubMed ID: 17786207
[TBL] [Abstract][Full Text] [Related]
11. The p85α regulatory subunit of PI3K mediates cAMP-PKA and retinoic acid biological effects on MCF7 cell growth and migration.
Donini CF; Di Zazzo E; Zuchegna C; Di Domenico M; D'Inzeo S; Nicolussi A; Avvedimento EV; Coppa A; Porcellini A
Int J Oncol; 2012 May; 40(5):1627-35. PubMed ID: 22366926
[TBL] [Abstract][Full Text] [Related]
12. Cellular and molecular determinants of all-trans retinoic acid sensitivity in breast cancer: Luminal phenotype and RARα expression.
Centritto F; Paroni G; Bolis M; Garattini SK; Kurosaki M; Barzago MM; Zanetti A; Fisher JN; Scott MF; Pattini L; Lupi M; Ubezio P; Piccotti F; Zambelli A; Rizzo P; Gianni' M; Fratelli M; Terao M; Garattini E
EMBO Mol Med; 2015 Jul; 7(7):950-72. PubMed ID: 25888236
[TBL] [Abstract][Full Text] [Related]
13. Loss of anti-proliferative effect of all-trans retinoic acid in advanced stage of breast carcinogenesis.
Ahn EH; Chang CC; Talmage DA
Anticancer Res; 2009 Aug; 29(8):2899-904. PubMed ID: 19661293
[TBL] [Abstract][Full Text] [Related]
14. All-trans-retinoic acid mediates G1 arrest but not apoptosis of normal human mammary epithelial cells.
Seewaldt VL; Kim JH; Caldwell LE; Johnson BS; Swisshelm K; Collins SJ
Cell Growth Differ; 1997 Jun; 8(6):631-41. PubMed ID: 9185997
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers.
Alsafadi S; Even C; Falet C; Goubar A; Commo F; Scott V; Quidville V; Albiges L; Dieci MV; Guegan J; Lazar V; Ahomadegbe JC; Delaloge S; André F
Clin Breast Cancer; 2013 Oct; 13(5):401-8. PubMed ID: 23830798
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA networks regulated by all-trans retinoic acid and Lapatinib control the growth, survival and motility of breast cancer cells.
Fisher JN; Terao M; Fratelli M; Kurosaki M; Paroni G; Zanetti A; Gianni M; Bolis M; Lupi M; Tsykin A; Goodall GJ; Garattini E
Oncotarget; 2015 May; 6(15):13176-200. PubMed ID: 25961594
[TBL] [Abstract][Full Text] [Related]
17. Derangement of a factor upstream of RARalpha triggers the repression of a pleiotropic epigenetic network.
Corlazzoli F; Rossetti S; Bistulfi G; Ren M; Sacchi N
PLoS One; 2009; 4(1):e4305. PubMed ID: 19173001
[TBL] [Abstract][Full Text] [Related]
18. Aromatase activity induction in human adipose fibroblasts by retinoic acids via retinoic acid receptor α.
Wilde J; Erdmann M; Mertens M; Eiselt G; Schmidt M
J Mol Endocrinol; 2013 Oct; 51(2):247-60. PubMed ID: 24023268
[TBL] [Abstract][Full Text] [Related]
19. Suppression of mammary carcinoma growth by retinoic acid: proapoptotic genes are targets for retinoic acid receptor and cellular retinoic acid-binding protein II signaling.
Donato LJ; Noy N
Cancer Res; 2005 Sep; 65(18):8193-9. PubMed ID: 16166294
[TBL] [Abstract][Full Text] [Related]
20. Myoepithelial and luminal breast cancer cells exhibit different responses to all-trans retinoic acid.
Berardi DE; Flumian C; Campodónico PB; Urtreger AJ; Diaz Bessone MI; Motter AN; Bal de Kier Joffé ED; Farias EF; Todaro LB
Cell Oncol (Dordr); 2015 Aug; 38(4):289-305. PubMed ID: 26044847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
